Tagged with engagement

Steven Hildemann, MD, PHD – EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety and Patient Affairs, Ipsen

Global Steven Hildemann, MD, PHD – EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety and Patient Affairs, Ipsen

Global Two years into his role, Ipsen’s EVP and Chief Medical Officer Prof. Dr. med. Steven Hildemann MD discusses his vision of patient-centricity and how he is leading a medical transformation that puts data-driven insights at the core and aims to make a real difference to both clinical practice and patients’…

Patient Engagement Roundtable: Novartis

InFocus Patient Engagement Roundtable: Novartis

InFocus BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Patient Engagement Roundtable: A Varied Global Picture As complex cutting-edge therapies come online, industry sponsors are increasingly looking to engage with patients, caregivers, and advocacy groups earlier and more broadly in the drug development…

CGT, Real World Evidence & The Patient Experience

InFocus CGT, Real World Evidence & The Patient Experience

InFocus BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME CGT, Real World Evidence & The Patient Experience One of the enduring conundrums around ground-breaking and potentially paradigm-shifting treatments such as CAR-T is the ever-thorny question of how fast to move them to market…

CAR-T and the Art of Managing Expectations

InFocus CAR-T and the Art of Managing Expectations

InFocus BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME CAR-T and the Art of Managing Expectations Chimeric antigen receptor (CAR-T) therapy was first approved by the US FDA back in 2017 amid a great deal of fanfare and high expectations among patients about…

Rendering CGT Genuinely Patient Centric

InFocus Rendering CGT Genuinely Patient Centric

InFocus BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Rendering CGT Genuinely Patient Centric In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially pertinent now that many innovative drug makers…

Marc Boutin – Global Head of Patient Engagement

InFocus Marc Boutin – Global Head of Patient Engagement

InFocus BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Marc Boutin Global Head of Patient Engagement, novartis SHARE Share on twitter Share on linkedin “How are you today?” For patients, this question may be a challenge. Honest answers can stop a conversation straight away. I know…

InFocus Patient Engagement in the Era of CAR-T

InFocus InFocus Patient Engagement in the Era of CAR-T

InFocus HOMEPAGE Patient Engagement in the Era of CAR-T In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially pertinent now that many innovative drug makers are seeking to become much more than just purveyors of pills and expand…

Interview: Richie Etwaru – Chief Digital Officer (CDO), IMS Health (Part 2)

Pharma Interview: Richie Etwaru – Chief Digital Officer (CDO), IMS Health (Part 2)

Pharma In part II of an exclusive interview at the eyeforpharma Barcelona Summit 2016, IMS Health’s Chief Digital Officer Richie Etwaru lifts the lid on the concept of Orchestrated Customer Engagement (OCE) and explains how it can demonstrably advance the ideals of patient centrality, inter-stakeholder trust and industry-wide operability. You have been pioneering…

Interview: Jorg Janssen – Managing Director, Lygature, The Netherlands

pharma Interview: Jorg Janssen – Managing Director, Lygature, The Netherlands

pharma Lygature is the new name of TI Pharma and CTMM, two internationally renowned public-private-partnerships turned non-for-profit partnership drivers. Managing Director Jorg Janssen explains that it will be business as usual for the merged organization, but with more opportunities for cross-disciplinary collaborations than ever before. Lygature drives partnerships for the development of…